194 related articles for article (PubMed ID: 30509104)
21. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer.
Li J; Ying Y; Xie H; Jin K; Yan H; Wang S; Xu M; Xu X; Wang X; Yang K; Zheng X; Xie L
FASEB J; 2019 Jan; 33(1):1374-1388. PubMed ID: 30138038
[TBL] [Abstract][Full Text] [Related]
22. EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway.
Wang L; Sun H; Wang X; Hou N; Zhao L; Tong D; He K; Yang Y; Song T; Yang J; Huang C
Oncotarget; 2016 Jul; 7(29):45302-45316. PubMed ID: 27244890
[TBL] [Abstract][Full Text] [Related]
23. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
24. MiR-203a-3p targets PTEN to promote hepatocyte proliferation by regulating PI3K/Akt pathway in BRL-3A cells.
Zhang Y; Zheng Y; Zhu G
Biosci Biotechnol Biochem; 2020 Apr; 84(4):725-733. PubMed ID: 31814541
[TBL] [Abstract][Full Text] [Related]
25. miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.
Wang J; Zhao X; Shi J; Pan Y; Chen Q; Leng P; Wang Y
Oncol Rep; 2016 Oct; 36(4):2049-58. PubMed ID: 27571748
[TBL] [Abstract][Full Text] [Related]
26. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X
Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801
[TBL] [Abstract][Full Text] [Related]
27. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
[TBL] [Abstract][Full Text] [Related]
28. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
[TBL] [Abstract][Full Text] [Related]
29. MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.
Yao K; He L; Gan Y; Zeng Q; Dai Y; Tan J
Diagn Pathol; 2015 Aug; 10():146. PubMed ID: 26290438
[TBL] [Abstract][Full Text] [Related]
30. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of miRNA-30c and miR-203a is associated with hepatitis C virus core protein-induced epithelial-mesenchymal transition in normal hepatocytes and hepatocellular carcinoma cells.
Liu D; Wu J; Liu M; Yin H; He J; Zhang B
Biochem Biophys Res Commun; 2015 Sep; 464(4):1215-1221. PubMed ID: 26210453
[TBL] [Abstract][Full Text] [Related]
32. Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
Noguchi S; Yasui Y; Iwasaki J; Kumazaki M; Yamada N; Naito S; Akao Y
Cancer Lett; 2013 Jan; 328(2):353-61. PubMed ID: 23104321
[TBL] [Abstract][Full Text] [Related]
33. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-203a inhibits breast cancer progression through the PI3K/Akt and Wnt pathways.
Entezari M; Soltani BM; Sadeghizadeh M
Sci Rep; 2024 Feb; 14(1):4715. PubMed ID: 38413784
[TBL] [Abstract][Full Text] [Related]
35. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z
Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164
[TBL] [Abstract][Full Text] [Related]
37. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
38. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
[TBL] [Abstract][Full Text] [Related]
39. MiR-125a-5p suppresses bladder cancer progression through targeting FUT4.
Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
Biomed Pharmacother; 2018 Dec; 108():1039-1047. PubMed ID: 30372804
[TBL] [Abstract][Full Text] [Related]
40. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
Wang X; Liang Z; Xu X; Li J; Zhu Y; Meng S; Li S; Wang S; Xie B; Ji A; Liu B; Zheng X; Xie L
Cell Death Dis; 2016 Dec; 7(12):e2503. PubMed ID: 27906180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]